TITLE

Letter to the Editor: A Multisite Study of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass

AUTHOR(S)
Hussain, A.; El-Hasani, S.
PUB. DATE
September 2013
SOURCE
Obesity Surgery;Sep2013, Vol. 23 Issue 9, p1454
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "A Multisite Study of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass" in a previous issue.
ACCESSION #
89438731

 

Related Articles

  • The Authors Respond: A Multisite Study of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass. Arterburn, David; Campos, Guilherme; Haneuse, Sebastien; Sherwood, Nancy; Bogart, Andy; Sidney, Stephen; Coleman, Karen; Theis, Mary; O'Connor, Patrick; Fisher, David // Obesity Surgery;Sep2013, Vol. 23 Issue 9, p1456 

    A response from the author of the article "A Multisite Study of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass" in a previous issue is presented.

  • Diabetes free with gastric bypass surgery.  // Podiatry Now;Aug2009, Vol. 12 Issue 8, p11 

    The author reports that a new study has found that almost 90 percent of morbidly obese patients with type 2 diabetes experience diabetes resolution in the first year after gastric bypass surgery.

  • 20: Gastric Bypass: A Miracle Cure for Diabetes? TRIVEDI, BIJAL // Discover;Jan/Feb2013, Vol. 34 Issue 1, p37 

    The article discusses research conducted in 2012 into the treatment of diabetes in obese people with gastric bypass surgery by researchers at Catholic University of Rome and the Cleveland Clinic in Ohio.

  • In This Issue of Diabetes. Bingham, Max // Diabetes;Nov2015, Vol. 64 Issue 11, p3629 

    The article discusses several diabetes-related studies published within the issue on topics including the mechanisms involved in sweetness suppression by leptin, the relevant effects of a highly specific peptide called CavNOxin, and the health benefits of exercise following gastric bypass surgery.

  • Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission. Diabetes 2014;63:1214-1223. Pontiroli, Antonio E. // Diabetes;Apr2014, Vol. 63 Issue 4, pe3 

    A letter to the editor is presented in response to the article "Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission" by R. Dutia and colleagues, published in the 2014 issue.

  • Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission. Diabetes 2014;63:1214-1223. Dutia, Roxanne; Brakoniecki, Katrina; Bunker, Phoebe; Paultre, Furcy; Homel, Peter; Carpentier, André C.; McGinty, James; Laferrère, Blandine // Diabetes;Apr2014, Vol. 63 Issue 4, pe4 

    A response by R. Dutia and colleagues to a letter to the editor about their article "Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission" in the 2014 issue is presented.

  • Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin. PADWAL, RAJ S.; GABR, RANIAH Q.; SHARMA, ARYA M.; LANGKAAS, LEE-ANN; BIRCH, DAN W.; KARMALI, SHAHZEER; BROCKS, DION R. // Diabetes Care;Jun2011, Vol. 34 Issue 6, p1295 

    OBJECTIVE--Use of gastric bypass surgery is common and increasing Over 40% of patients in diabetes remission after gastric bypass surgery may redevelop diabetes within 5 years. Metformin, the first-line drug for diabetes, has low bioavailability and slow, incomplete gastrointestinal absorption....

  • Refractory Hyperglycemia After Gastric Bypass Surgery: A Novel Subtype of Type 2 Diabetes? Rubino, Francesco; Shukla, Alpana P.; Cummings, David E.; Rosenbaum, Matthew W.; Soni, Ashwin; Mingrone, Geltrude // Diabetes Care;Dec2014, Vol. 37 Issue 12, pe254 

    The article discusses a study that examined patients with refractory post Roux-en-Y gastric bypass (RYGB) hyperglycemia. Topics discussed include remission on majority of patients with type 2 diabetes (T2DM), the anti-diabetes mechanisms of RYGB as partially weight-independent and failure of...

  • Hormonal Changes After Roux-en Î¥ Gastric Bypass For Morbid Obesity and the Control of Type-II Diabetes Mellitus. Clements, Ronald H.; Gonzalez, Quintin H.; Long, Calvin I.; Wittert, Gary; Laws, Henry L. // American Surgeon;Jan2004, Vol. 70 Issue 1, p1 

    Morbid obesity (MO) is associated with diabetes mellitus-type II (DM-II). Roux-en Y gastric bypass (RNY) has been shown to normalize glucose intolerance in these patients through an incompletely understood mechanism. Gastrointestinal hormonal changes have been suggested as an explanation for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics